Gemina Laboratories Ltd. Stock
Equities
GLAB
CA3686501071
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 CAD | -.--% | -.--% | -7.41% |
04-02 | Gemina Laboratories Sign First Strategic License Agreement | CI |
03-18 | Gemina Laboratories Ltd. announced that it has received CAD 0.91 million in funding | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 44.87M 61.75M |
---|---|---|---|---|---|
Net income 2022 | -4M -5.5M | Net income 2023 | -5M -6.88M | EV / Sales 2022 | - |
Net cash position 2022 | 1.11M 1.53M | Net Debt 2023 | 158K 217K | EV / Sales 2023 | - |
P/E ratio 2022 |
-5.03
x | P/E ratio 2023 |
-7.05
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.82% |
Current month | +8.70% | ||
1 month | +13.64% | ||
3 months | -10.71% | ||
6 months | +4.17% | ||
Current year | -7.41% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Greene
FOU | Founder | - | 17-10-09 |
Brian Firth
CEO | Chief Executive Officer | - | 22-09-05 |
Stephen Davies
FOU | Founder | 74 | 17-10-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Davies
FOU | Founder | 74 | 17-10-09 |
Robert Greene
FOU | Founder | - | 17-10-09 |
Robert Porter
PSD | President | 54 | 22-12-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.5 | -.--% | 10,500 |
24-04-26 | 0.5 | -.--% | 11,500 |
24-04-25 | 0.5 | -.--% | 1,000 |
24-04-24 | 0.5 | -.--% | 24,000 |
24-04-23 | 0.5 | -.--% | 1,000 |
Delayed Quote Canadian Securities Exchange, April 30, 2024 at 11:11 am
More quotes1st Jan change | Capi. | |
---|---|---|
-7.41% | 26.84M | |
-0.60% | 12.63B | |
-9.59% | 7.67B | |
+1.82% | 5.42B | |
+0.02% | 4.57B | |
-52.61% | 3.51B | |
+6.42% | 2.59B | |
-14.59% | 2.05B | |
-8.29% | 1.79B | |
+1.83% | 1.77B |
- Stock Market
- Equities
- GLAB Stock